The Nasdaq Listing Qualifications Department provided the extension on January 10, 2024, allowing the company until July 8, 2024, to elevate its ordinary share closing bid price to at least $1.00 for a minimum of 10 consecutive business days. Throughout this extended compliance period, Qilian's ordinary shares will remain listed and continue trading on the Nasdaq Capital Market. JIUQUAN, China - Qilian International Holding Group Limited  NASDAQ QLI , a pharmaceutical and chemical products manufacturer based in China, has been granted an additional 180 days to meet the Nasdaq's minimum bid price requirement. To address the deficiency, Qilian is evaluating various strategies, including the possibility of a reverse stock split, to achieve compliance with the Nasdaq's requirement.
Qilian International Holding Group Limited (QLI) has been granted an extension until July 8, 2024, to meet Nasdaq's minimum bid price requirement of $1.00 for 10 consecutive business days. The company is considering a reverse stock split to achieve compliance.